References
Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TWR (2014) A review of the surgical management of sacral chordoma. Eur J Surg Oncol: EJSO 40:1412–1420
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstem AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379. doi:10.1016/S0895-4356(96)00236-3
Freiman JA, Chalmers TC, Smith H, Kuebler RR, Smith H Jr, Kuebler RR (1978) The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med 299(13):690–694. doi:10.1056/NEJM197809282991304
Smith DL, Soria JC, Morat L et al (2004) Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11(1):45–51. doi:10.1007/BF02524345
Gonzalez-Sistal A, Sanchez AB, Del Rio MC, Arias JI, Herranz M, Ruibal A (2014) Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. Anticancer Res 34(1):269–273. http://www.ncbi.nlm.nih.gov/pubmed/24403473
Zou M-X, Lv G-H, Li J, She X-L, Jiang Y (2016) Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis. Am J Transl Res 8(2):516–529. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846901/
von Witzleben A, Goerttler LT, Lennerz J et al (2015) In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. Eur Spine J 1–9. doi:10.1007/s00586-015-4242-1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Ruosi, C., Colella, G., Di Donato, S.L. et al. Answer to the Letter to the Editor of J. Li et al. concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917). Eur Spine J 26, 283–284 (2017). https://doi.org/10.1007/s00586-016-4824-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-016-4824-6